Belizário, J. E., & Faintuch, J. (2018). Microbiome and Gut Dysbiosis. In R. Silvestre, & E. Torrado (Eds.), Metabolic Interaction in Infection (1st ed., pp. 459–476). DOI: 10.1007/978-3-319-74932-7_13
Hawrelak, J. A., & Myers, S. P. (2004). The causes of intestinal dysbiosis: a review. Alternative Medicine Review, 9(2): 180-197. Retrieved from https://pubmed.ncbi.nlm.nih.gov/15253677/
McFarland, L.V. (2014). Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open, 4(8): e005047. DOI: 10.1136/bmjopen-2014-005047
Meng, X., Zhang, G., Cao, H., Yu, D., Fang, X., de Vos, W. M., & Wu, H. (2020). Gut dysbacteriosis and intestinal disease: mechanism and treatment. Journal of Applied Microbiology, 129(4): 787–805. DOI: 10.1111/jam.14661
Perrotta, G. (2021) Intestinal dysbiosis: definition, clinical implications, and proposed treatment protocol (Perrotta Protocol for Clinical Management of Intestinal Dysbiosis, PID) for the management and resolution of persistent or chronic dysbiosis. Archives of Clinical Gastroenterology, 7(2): 056-063. DOI: 10.17352/2455-2283.000100
Sharma, S., & Tripathi, P. (2019). Gut microbiome and type 2 diabetes: Where we are and where to go? The Journal of Nutritional Biochemistry, 63, 101–108. DOI: 10.1016/j.jnutbio.2018.10.003
Shaw, K. A., Bertha, M., Hofmekler, T., Chopra, P., Vatanen, T., Srivatsa, A., … Kugathasan, S. (2016). Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Medicine, 8(1). DOI: 10.1186/s13073-016-0331-y
Weiss, G. A., & Hennet, T. (2017). Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences, 74(16): 2959–2977. DOI: 10.1007/s00018-017-2509-x